Adenosine 5'-triphosphate-4-carboxamide-ribofuranosylthiazole

US4446315A · kind A · utility

Assignee

• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Victor E. Marquez · Gaithersburg, US
• David A. Cooney · Bethesda, US
• Gulilat Gebeyehu · Silver Spring, US
• Hiremagalur N. Jayaram · Indianapolis, US

Key dates

• Filing date: Sep 24, 1982
• Grant date: May 1, 1984
• Expiry date: Sep 24, 2002

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07H19/207
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to the preparation of and the antitumor compound, adenosine 5'-(trihydrogen diphosphate) 5'.fwdarw.5'-ester with 4-carboxamide-2-.beta.-D-ribofuranosylthiazole.